Efficacy, Safety and tolerability of the once-daily 10 cm² rivastigmine patch formulation in the patients with dementia (with probable Alzheimer’s disease). Bangla. J. Neuroscience. 2013;29(1):5-14. doi:10.3329/bjn.v29i1.56165